HLTPHA027 — Apply knowledge of malignant diseases and immunosuppressive disorders to dispense medication

Generate a complete, audit-ready assessment tool for this unit in minutes: candidate assessment, assessor guide with model answers, and a coverage matrix mapped to every component below. Reviewed and approved by your qualified person, exported under your branding.

Generate HLTPHA027 free See a real sample

Every new account includes a free credit — no card, no subscription.

What an assessment for HLTPHA027 must cover

27 assessable components: 4 elements (14 performance criteria), 3 performance evidence and 10 knowledge evidence requirements. An audit-defensible tool maps every question and task back to these — that mapping is the coverage matrix Auditori generates alongside the assessment.

Elements & performance criteria

1 Identify medication to treat malignant diseases and immunosuppressive disorders.

1.1Identify the malignant diseases and immunosuppressive disorders being treated.
1.2Identify the factors that lead to the successful medicinal treatment of malignant diseases and immunosuppressive disorders.
1.3Consult authorised personnel to verify the successful medicinal treatment of malignant diseases and immunosuppressive disorders.

2 Prepare appropriate medication to treat malignant diseases and immunosuppressive disorders to dispense to patients.

2.1Identify the appropriate malignant diseases and immunosuppressive disorders medication to be dispensed to patients in accordance with Work Health and Safety (WHS) policies, guidelines and symbols.
2.2Confirm the medication to be dispensed to the patient with an authorised person and prepare as directed.

3 Prepare to provide a continuing medication education session for peers.

3.1Obtain and read presentation materials for continuing medication education session.
3.2Chose a delivery method for the continuing medication education session.
3.3Make arrangements, including time, venue and logistical issues for the delivery of the continuing medication education session.

4 Deliver the continuing medication education session for peers.

4.1Describe malignant diseases, immunodeficiency and musculoskeletal disorders and associated symptoms for each disorder.
4.2Explain common supportive care treatments as approved by an authorised person.
4.3Explain the main effects of common medicines used for each of the disorders.
4.4Refer to appropriate references to identify the requirements relating to the findings.
4.5Use patient case studies to demonstrate treatment types, duration, side effects and further treatment.
4.6Present the standard medication references and your organisation’s prescribed policies.

Performance evidence

prepare and dispense Immunosuppressive medication on at least 10 occasions, including: demonstrating the ability to source information; confirming medication dispensing with an authorised person
provide a continuing medication education session focusing on the pharmaceutical aspects, that includes: at least two malignant diseases, focussing on the appropriate supportive care treatments and the reasons for their use; at least one condition that requires immunosuppressive medication; session delivery methods, including: digital presentation; demonstration; referral to findings; activities and questions
perform the activities outlined in the performance criteria of this unit during a period of 240 hours of work related to hospital pharmacy support in a clinical workplace environment. These 240 hours may be applied collectively across all units of competency that include the requirement for workplace hours for the purposes of assessment.

Knowledge evidence

understand information on malignant diseases and immunosuppressive disorders including: malignant diseases and immune related disorders that require immunosuppressive medication and determine appropriate treatments and reasons for their use; medication used for each treatment and the supportive care medications required; side effects of the medication; adverse reactions to medication that require referral to an authorised person; relevant information for review by an authorised person
standard pharmaceutical references, including: Australian Medicines Handbook (AMH); Australian Pharmaceutical Formulary Handbook (APF); Monthly Index of Medical Specialities (MIMS) or AusDI Advanced; Micromedex
relevant National, State or Territory regulatory and legislative requirements
the legal responsibilities of providers of health care in relation to confidentiality, patient rights, duty of care and implications of negligence
limitations of own work role including identification and referring of issues outside scope of own practice to the authorised person
Work Health and Safety (WHS) policies, guidelines and symbols and their relevance to dispensing medication
common malignant diseases: carcinoma; leukaemia; lymphoma; melanomas
basic difference between healthy and malignant cells: growth in contrast to normal cells, cancer cells do not stop growing and dividing that results in the formation of a tumour; communication including cancer cells do not interact with other cells as normal cells do; cell repair and cell death including normal cells are either repaired or undergo apoptosis when they are damaged or get old, whereas cancer cells don’t undergo apoptosis
the role of common supportive care medications for oncology patients and non-pharmacology methods to improve quality of life
presentation methods for continuing education.

Unit content sourced from training.gov.au — © Commonwealth of Australia, licensed under CC BY 4.0. Auditori is not affiliated with the Department of Employment and Workplace Relations.

See what you get before you start

Real, unedited Auditori output (RIIHAN201E shown), branded for a sample RTO:

Questions about assessing HLTPHA027

What does an assessment tool for HLTPHA027 need to cover?

To satisfy the Principles of Assessment and Rules of Evidence, an assessment for HLTPHA027 needs to address all 27 unit components: 4 elements with 14 performance criteria, 3 performance evidence requirements, 10 knowledge evidence requirements, and the foundation skills. A coverage matrix mapping each question and task to these components is what an auditor looks for.

How does Auditori generate an assessment tool for HLTPHA027?

Auditori pulls the current release of HLTPHA027 from training.gov.au and generates a complete package: candidate assessment, assessor guide with model answers and observation criteria, and a coverage matrix mapping every component. A suitably qualified person then reviews and approves the draft in a built-in workflow — consistent with ASQA's guidance on AI use in VET — before export as branded PDF and editable Word.

Is the first assessment tool really free?

Yes. Every new account includes one free credit — enough to generate the complete assessment tool for HLTPHA027 — with no card and no subscription required. After that it's pay-as-you-go per unit.

Can I check my existing HLTPHA027 assessment instead of generating a new one?

Yes — upload your existing assessment or learner guide and Auditori maps it against every element, performance criterion, PE and KE of HLTPHA027, showing exactly what's covered and what's missing. Mapping costs a quarter of a credit.

Related units

Your HLTPHA027 assessment tool, in minutes.

First unit free. No card, no RTO registration, no subscription.

Generate HLTPHA027 free